<DOC>
	<DOCNO>NCT00916955</DOCNO>
	<brief_summary>The purpose project determination deletion DNA chromosome 22 q11.2 band cause phenotype observe velo-cardio-facial syndrome ( VCFS ) . In word , purpose remain genotype-to-phenotype matching . Current method include use whole genome chip microarray analysis . Blood sample collect DNA every patient consent VCFS Center Upstate Medical University . They examine phenotypic feature consistent typical clinical evaluation . The information examination enter anonymously database . Genomic information match clinical phenotype appropriate statistical method apply .</brief_summary>
	<brief_title>Genetic Modifiers 22q11.2 Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>DiGeorge Syndrome</mesh_term>
	<criteria>FISH confirm diagnosis 22q11.2 deletion syndrome</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>22q11.2 deletion syndrome</keyword>
	<keyword>velo-cardio-facial syndrome</keyword>
	<keyword>congenital anomaly</keyword>
	<keyword>mental illness</keyword>
	<keyword>congenital heart disease</keyword>
</DOC>